Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 200 shares, a decline of 99.9% from the November 30th total of 291,200 shares. Based on an average trading volume of 34,938,700 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Price Performance

ENZC stock traded up $0.00 during midday trading on Friday, hitting $0.00. The company’s stock had a trading volume of 7,346,088 shares, compared to its average volume of 11,030,960. Enzolytics has a 1 year low of $0.00 and a 1 year high of $0.02.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.